More about

Thyroid

News
April 15, 2025
2 min read
Save

Use risk stratification to guide treatment of papillary thyroid microcarcinomas

Rather than tumor size alone, the American Thyroid Association’s risk stratification system should be used when assessing papillary thyroid microcarcinomas, according to data published in The Journal of Clinical Endocrinology & Metabolism.

News
April 02, 2025
3 min read
Save

Age, clinical activity may affect glucocorticoid therapy response for thyroid eye disease

Older adults and those with a worse thyroid eye disease clinical activity score at baseline were less likely to respond to glucocorticoid therapy, according to findings published in Thyroid.

News
March 06, 2025
3 min read
Save

Thyroid cancer incidence plateaued during 2010s after rising from 1975 to 2009

After rising over a 35-year period, thyroid cancer incidence in the U.S. plateaued from 2010 to 2019, according to findings published in The Lancet Diabetes & Endocrinology.

News
February 26, 2025
6 min watch
Save

VIDEO: Collaborative effort needed for managing Graves’ disease during pregnancy

In this Healio Video Exclusive, Nicole Gomez, MD, speaks with Caroline T. Nguyen, MD, about managing Graves’ disease during pregnancy.

News
January 23, 2025
3 min read
Save

Increased screening may lead to higher thyroid cancer risk after GLP-1 initiation

Adults with type 2 diabetes using a GLP-1 drug have a similar risk for thyroid cancer as those using other diabetes drugs, though increased thyroid cancer risk was observed in the first year after GLP-1 initiation, researchers reported.

News
January 22, 2025
14 min read
Save

The changing landscape of endocrinology: GLP-1s, new diabetes technology and more

The field of endocrinology saw many advancements in 2024 and more developments and innovations are anticipated in 2025.

News
January 22, 2025
1 min read
Save

Endocrinology Drug and Device Update

In a review of the 2024 milestones, Healio | Endocrine Today compiled a list of drugs and devices related to the field that were newly approved, cleared or had label or indication changes. Information was gathered from the FDA website and news releases. We put our best effort into making a complete list and regret any omission. Appearance of a drug or device does not constitute any endorsement by Healio | Endocrine Today, its editors, publishers or editorial board. — The Editors

News
October 02, 2024
2 min read
Save

Timing of mild maternal hypothyroidism ‘pivotal’ for predicting pregnancy outcomes

Third-trimester subclinical hypothyroidism and first- and third-trimester isolated maternal hypothyroxinemia were tied to various adverse pregnancy outcomes, highlighting the importance of trimester-specific thyroid function evaluations.

News
September 09, 2024
1 min read
Save

Once-weekly batoclimab lowers immunoglobulin for adults with uncontrolled Graves’ disease

Most adults who had uncontrolled Graves’ disease on antithyroid drugs responded to once-weekly subcutaneous batoclimab, according to top-line results released by Immunovant.

News
August 28, 2024
3 min read
Save

Teprotumumab does not raise rates of hearing-related adverse events in thyroid eye disease

Adults receiving teprotumumab for the treatment of thyroid eye disease experience a similar number of hearing-related adverse events as those not treated with teprotumumab, according to new data.

View more